AHA Statement on Decision by U.S. Supreme Court to Hear AHA Case on 340B Payment Cuts

Melinda Hatton
General Counsel
American Hospital Association

July 2, 2021

We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients. We are hopeful that the Court will reject the appellate court decision deferring to the government’s interpretation of the law that clearly imperils the important services that the 340B program helps allow eligible hospitals and health systems to provide to vulnerable communities, many of which would otherwise be unavailable.


Contact:        Colin Milligan, (202) 638-5491, cmilligan@aha.org

Marie Johnson, (202) 626-2351, mjohnson@aha.org


Related Resources

Special Bulletin
Download the AHA Special Bulletin: CMS Issues Hospital Outpatient/ASC Proposed Rule, Including Modifications to Price Transparency Rule
Advancing Health Podcast
Columbus, Ohio-based Mount Carmel Health System goes beyond the walls of its hospital to serve its community and patients through programs such as Street…
Amy Bricker President Express Scripts PBM 1 Express Way Saint Louis, MO 63121 Dear Ms. Bricker:
Action Alert
Please contact your members of Congress and urge them to support legislation that will provide certainty to hospitals participating in the 340B Drug Pricing…
The AHA expresses support for legislation  H.R. 3203 introduced in the House that would provide certainty to hospitals participating in the 340B Drug Pricing…
The AHA and five other health care organizations sent the attached letter to HHS Secretary Becerra urging him to stop the actions of six drug companies that…